The burden of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB
This infographic shows the burden in the EU of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB based on data from the 2014 surveillance report
Public health guidance on management of contacts of MDR TB and XDR TB patients
The goal of this guidance is to contribute towards preventing as many MDR TB and XDR TB cases as possible in the EU/EEA. Given that MDR TB and XDR TB is becoming more prevalent, the issue of how to manage contacts of MDR TB patients is becoming increasingly relevant. The specific aim of this document is to provide guidance on issues relevant to the management of contacts of MDR TB and XDR TB patients.
Tuberculosis - Annual Epidemiological Report, 2016 [2014 data]
In 2014, 58 008 cases of TB were reported in 29 EU/EEA countries (Table 1). As in previous years, three countries (Poland, Romania and the United Kingdom) accounted for approximately 50% of all reported cases, with Romania alone accounting for 27%.
Adverse Events in Healthy Individuals and MDR-TB Contacts Treated with Anti-Tuberculosis Drugs Potentially Effective for Preventing Development of MDR-TB: A Systematic Review
Langendam, M.W., Tiemersma, E.W., van der Werf, M.J., Sandgren, A.
Availability of anti-tuberculosis drugs in Europe
Sotgiu, G., D'Ambrosio, L., Centis, R., Bothamley, G., Cirillo, D.M., de Lorenzo, S., Guenther, G., Kliiman, K., Muetterlein, R., Spinup, V., Villar, M., Zellweger, J.-P., Sandgren, A., Huitric, E., Lange, C., Manissero, D., Migliori, G.B.
Drug resistance among tuberculosis cases in the European Union and European economic area, 2007 to 2012
Van Der Werf M.J., Ködmön, C., Hollo, V., Sandgren, A., Zucs, P.
Molecular surveillance of multi- and extensively drug-resistant tuberculosis transmission in the European Union from 2003 to 2011
De Beer, J.L., Ködmön, C., van der Werf, MJ., van Ingen, J., van Soolingen, D., the ECDC MDR-TB molecular surveillance project participants